Lyka Labs Q3 Results
- BSE: 500259
- NSE: LYKALABS
- ISIN: INE933A01014
- Sector: Biotechnology & Drugs
BSE
147
3.65 (2.55%)
3.65 (2.55%)Volume12.87 K
Updated: Mon 25 Nov, 2024 | 15:28:54
NSE
146.994.23 (2.96%)
4.23 (2.96%)Volume84.27 K
Updated: Mon 25 Nov, 2024 | 15:29:55
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Lyka Labs Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 23 | Sep 23 | QoQ Comp | Dec 22 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 32.56 | 27.99 | -% | 17.82 | -% |
| Selling/ General/ Admin Expenses Total | 7.17 | 6.44 | -% | 4.59 | -% |
| Depreciation/ Amortization | 2.84 | 3.59 | -% | 3.47 | -% |
| Other Operating Expenses Total | 6.85 | 5.68 | -% | 5.03 | -% |
| Total Operating Expense | 28.54 | 27.84 | -% | 26.09 | -% |
| Operating Income | 4.02 | 0.15 | -% | -8.27 | -% |
| Net Income Before Taxes | 3.29 | -0.79 | -% | -10.29 | -% |
| Net Income | 1.78 | -0.49 | -% | -10.42 | -% |
| Diluted Normalized EPS | 0.53 | -0.07 | -% | -2.04 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST - Markets
02C2C Advanced Systems IPO Day 2: Check GMP, subscription status and other key details
2 min read06:59 PM IST - Markets
03Stocks to buy or sell: Dharmesh Shah of ICICI Securities recommends buying L&T, Syngene International on November 25
5 min read10:00 AM IST